170 related articles for article (PubMed ID: 17663188)
1. Determination of olmesartan medoxomil in tablets by UV-Vis spectrophotometry.
Celebier M; Altinoz S
Pharmazie; 2007 Jun; 62(6):419-22. PubMed ID: 17663188
[TBL] [Abstract][Full Text] [Related]
2. HPTLC method for estimation of olmesartan medoxomil in tablet formulation with stability studies.
Verma PK; Kamboj VK
Pak J Pharm Sci; 2013 Jan; 26(1):209-15. PubMed ID: 23261750
[TBL] [Abstract][Full Text] [Related]
3. RP-HPLC-DAD method for determination of olmesartan medoxomil in bulk and tablets exposed to forced conditions.
Sharma RN; Pancholi SS
Acta Pharm; 2010 Mar; 60(1):13-24. PubMed ID: 20228038
[TBL] [Abstract][Full Text] [Related]
4. Ratio spectra derivative and zero-crossing difference spectrophotometric determination of olmesartan medoxomil and hydrochlorothiazide in combined pharmaceutical dosage form.
Rote AR; Bari PD
AAPS PharmSciTech; 2009; 10(4):1200-5. PubMed ID: 19862625
[TBL] [Abstract][Full Text] [Related]
5. Stability-indicating method for simultaneous estimation of olmesartan medoxomile, amlodipine besylate and hydrochlorothiazide by RP-HPLC in tablet dosage form.
Jain PS; Patel MK; Gorle AP; Chaudhari AJ; Surana SJ
J Chromatogr Sci; 2012 Sep; 50(8):680-7. PubMed ID: 22593253
[TBL] [Abstract][Full Text] [Related]
6. Spectrophotometric determination of rosuvastatin calcium in tablets.
Uyar B; Celebier M; Altinoz S
Pharmazie; 2007 Jun; 62(6):411-3. PubMed ID: 17663185
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of a high-performance liquid chromatographic method for determination of eprosartan in bulk drug and tablets.
Patel HU; Suhagia BN; Patel CN
J AOAC Int; 2010; 93(6):1862-7. PubMed ID: 21313813
[TBL] [Abstract][Full Text] [Related]
8. Identification and determination of selected angiotensin II receptor antagonist group drugs by HPLC method.
Czerwińska K; Mazurek AP
Acta Pol Pharm; 2011; 68(6):831-7. PubMed ID: 22125946
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous determination of atorvastatin calcium and olmesartan medoxomil in a pharmaceutical formulation by reversed phase high-performance liquid chromatography, high-performance thin-layer chromatography, and UV spectrophotometric methods.
Soni H; Kothari C; Khatri D; Mehta P
J AOAC Int; 2014; 97(3):791-7. PubMed ID: 25051627
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous spectrofluorimetric determination of amlodipine besylate and valsartan in their combined tablets.
Shaalan RA; Belal TS
Drug Test Anal; 2010 Oct; 2(10):489-93. PubMed ID: 20872895
[TBL] [Abstract][Full Text] [Related]
11. Improved analytical validation and pharmacokinetics of valsartan using HPLC with UV detection.
Piao ZZ; Lee ES; Tran HT; Lee BJ
Arch Pharm Res; 2008 Aug; 31(8):1055-9. PubMed ID: 18787797
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of an UV spectrophotometric method for determination of gatifloxacin in tablets.
Salgado HR; Oliveira CL
Pharmazie; 2005 Apr; 60(4):263-4. PubMed ID: 15881604
[TBL] [Abstract][Full Text] [Related]
13. Stability-indicating UPLC method for determination of Valsartan and their degradation products in active pharmaceutical ingredient and pharmaceutical dosage forms.
Krishnaiah Ch; Reddy AR; Kumar R; Mukkanti K
J Pharm Biomed Anal; 2010 Nov; 53(3):483-9. PubMed ID: 20646890
[TBL] [Abstract][Full Text] [Related]
14. Spectrophotometric methods for simultaneous determination of ternary mixture of amlodipine besylate, olmesartan medoxomil and hydrochlorothiazide.
Merey HA; Ramadan NK; Diab SS; Moustafa AA
Spectrochim Acta A Mol Biomol Spectrosc; 2014 May; 125():138-46. PubMed ID: 24534425
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous determination of olmesartan medoxomil and irbesartan and hydrochlorothiazide in pharmaceutical formulations and human serum using high performance liquid chromatography.
Sultana N; Arayne MS; Ali SS; Sajid S
Se Pu; 2008 Sep; 26(5):544-9. PubMed ID: 19160750
[TBL] [Abstract][Full Text] [Related]
16. Determination of lornoxicam in pharmaceutical preparations by zero and first order derivative UV spectrophotometric methods.
Nemutlu E; Demircan S; Kir S
Pharmazie; 2005 Jun; 60(6):421-5. PubMed ID: 15997830
[TBL] [Abstract][Full Text] [Related]
17. Stability indicating LC method for the simultaneous determination of amlodipine and olmesartan in dosage form.
Patil KR; Rane VP; Sangshetti JN; Yeole RD; Shinde DB
J Chromatogr Sci; 2010 Aug; 48(7):601-6. PubMed ID: 20819287
[TBL] [Abstract][Full Text] [Related]
18. High throughput microwell spectrophotometric assay for olmesartan medoxomil in tablets based on its charge-transfer reaction with DDQ.
Darwish IA; Wani TA; Khalil NY; Abdel-Rahman HM
Acta Pharm; 2014 Mar; 64(1):63-75. PubMed ID: 24670352
[TBL] [Abstract][Full Text] [Related]
19. The relative bioavailability and fasting pharmacokinetics of three formulations of olmesartan medoxomil 20-mg capsules and tablets in healthy Chinese male volunteers: An open-label, randomized-sequence, single-dose, three-way crossover study.
Li KY; Liang JP; Hu BQ; Qiu Y; Luo CH; Jiang Y; Lin XP; Yang N
Clin Ther; 2010 Aug; 32(9):1674-80. PubMed ID: 20974325
[TBL] [Abstract][Full Text] [Related]
20. Electrochemical determination of olmesartan medoxomil using hydrothermally prepared nanoparticles composed SnO2-Co3O4 nanocubes in tablet dosage forms.
Rahman MM; Khan SB; Faisal M; Rub MA; Al-Youbi AO; Asiri AM
Talanta; 2012 Sep; 99():924-31. PubMed ID: 22967644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
